Vaping Liability and Litigation Virtual Seminar Agenda
In recent years, vaping has come under intense scrutiny as its market presence has expanded. This cutting-edge virtual seminar will explore the science and toxicology behind vaping claims, a report of the current status of the multidistrict JUUL litigation pending in California, along with a discussion of anticipated future developments, and an exploration of the links between COVID-19 and vaping risks and liability.
Earn up to three hours of CLE credit while learning about this hot topic. View the CLE grid (PDF). View the speaker list.
This virtual seminar is $150 for DRI members and $250 for non-members.
For questions, call DRI Customer Service at 312.795.1101.
Click on the tab to expand the content.
Thursday, January 28, 2021
| Time (Central Time) | Session | Format | CLE |
|---|---|---|---|
| 12:00 p.m. | Welcome and Introduction J. Richard Moore, Bleeke Dillon Crandall, Indianapolis, IN Melissa Roeder, Foley & Mansfield PLLP, Seattle, WA | Live Stream | |
| 12:15 p.m. | "Toxi-Vaping" Impairment, Hazards and Litigation Join Angie and Melissa for a fast-paced discussion about vaping in America. The presenters will discuss:
Discuss and analyze the toxic effects of vaping and how our court system has responded to the same. Speakers: Angela Perez PhD, CTEH LLC, Portland, OR Melissa Roeder, Foley & Mansfield PLLP, Seattle, WA | Live Stream | 1.0 |
| 1:15 p.m. | BREAK | ||
| 1:25 p.m. | JUUL Litigation Update and Anticipated Future Developments Speakers: Angela Perez PhD, CTEH LLC, Portland, OR Melissa Roeder, Foley & Mansfield PLLP, Seattle, WA | Live Stream | 1.0 |
| 2:25 p.m. | BREAK | ||
| 2:35 p.m. | ZOOM ROUNDTABLE – JUUL LITIGATION DISCUSSION Moderator: Ed Ulloa, Hawkins Parnell & Young LLP, Los Angeles, CA | Zoom Rooms | |
| 3:05 p.m. | BREAK | ||
| 3:15 p.m. | Vaping and COVID-19 COVID-19 is primarily a respiratory disease. Vaping involves drawing air into the lungs. It was therefore only a matter of time before people asked whether vaping might increase susceptibility to or severity of COVID-19. However, the newness of COVID-19, and our limited understanding of its epidemiology and mechanisms, raise the question as to whether there is any causal connection between the exposure and the disease. Speaker: David Jaroslaw, DLA Piper, New York, NY | Live Stream | 1.0 |
| 4:15 p.m. | Networking Reception with Icebreakers | Zoom Rooms | |
| 5:15 p.m. | ADJOURN |